Provided by Tiger Fintech (Singapore) Pte. Ltd.

Seres Therapeutics

9.40
+0.09000.97%
Post-market: 9.400.00000.00%19:02 EDT
Volume:56.25K
Turnover:528.35K
Market Cap:81.95M
PE:537.05
High:9.70
Open:9.33
Low:9.17
Close:9.31
Loading ...
Mar 16, 2020

Correspondence

CORRESP [Cover] - Correspondence
Mar 02, 2020

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Mar 02, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 02, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 12, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 12, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 07, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 07, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Dec 16, 2019

Major Issues Report

Current report, item 5.02
Nov 27, 2019

Major Issues Report

Current report, items 1.01 and 9.01
Nov 12, 2019

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Nov 05, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Nov 05, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Nov 04, 2019

Major Issues Report

Current report, items 1.01, 2.03, and 9.01
Sep 09, 2019

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Sep 06, 2019

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Aug 06, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Aug 06, 2019

Statement Of Changes In Beneficial Ownership

Initial statement of beneficial ownership of securities
Aug 06, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]